HR Execs on the Move

GlaxoSmithKline

www.gsk.com

 
We are a science-led global healthcare company that researches and develops a broad range of innovative products in three primary areas of pharmaceuticals, vaccines and consumer healthcare. As one of the few healthcare companies researching both medicines and vaccines for the World Health Organization`s three priority diseases – HIV/AIDS, tuberculosis and malaria, we are very proud to have developed some of the leading global medicines in these fields. Our product portfolio also includes a range of consumer brands, many of which are household names around the world, including Sensodyne, Aquafresh, Horlicks, Panadol and Tums.
  • Number of Employees: 50K-100K
  • Annual Revenue: > $1 Billion
  • www.gsk.com
  • 5 Crescent Drive
    Philadelphia, PA USA 19112
  • Phone: 215.751.7160

Executives

Name Title Contact Details
Claudia Sandoval
Global Supply Chain 2030 Ambition Profile
Maria Behan
Senior Director of Marketing, TRELEGY Profile
Cindy Alisesky
VP Talent Acquisition. Onboarding and Profile
Joe Honeycutt
Director, Sales Force Effectiveness and Profile
Sonia Choi
Senior Vice President, Commercial Profile

Similar Companies

SubjectWell

SubjectWell provides risk-free patient recruitment for clinical trials. We engage the 96% of Americans who have never participated in clinical trials and we only charge for those who randomize.

ProTom International

Protoms Radiance 330 Proton Therapy System is compact, customizable, and has the industrys fastest return on investment.

Opko

OPKO Health is a diversified healthcare company that seeks to establish industry leading positions in large, rapidly growing markets. Our diagnostics business includes BioReference Laboratories, the nation`s third largest clinical laboratory with a core genetic testing business and a 400 person sales and marketing team to drive growth and leverage new products, including the 4Kscore® prostate cancer test and the Claros® 1 in office immunoassay platform. Our pharmaceutical business features RAYALDEE, an FDA approved treatment for SHPT in stage 3-¬4 CKD patients with vitamin D insufficiency (launched in November 2016), VARUBITM for chemotherapy induced nausea and vomiting (oral formulation launched by partner TESARO and IV formulation pending FDA approval), OPK88004, a once or twice weekly oxyntomodulin for type 2 diabetes and obesity, in Phase 2 clinical trials, among the new class of GLP-¬1 glucagon receptor dual agonists, and OPK88003, a selective androgen receptor modulator for benign prostatic hyperplasia (Phase 2). Our biologics business includes hGH-¬CTP, a once weekly human growth hormone in Phase 3 and partnered with Pfizer; and a long-¬acting Factor VIIa drug for hemophilia in Phase 2a.

Connecticut Orthopaedics

Connecticut Orthopaedics is a premier team of orthopaedic doctors, surgeons and health care professionals that keep you moving forward with life. Learn more

Alpharma, LLC

Alpharma, LLC is one of the leading companies in the Healthcare, Pharmaceuticals, & Biotech sector.